INOVIO PHARMACEUTICALS, INC. Deferred Federal Income Tax Expense (Benefit)
INOVIO PHARMACEUTICALS, INC. (INO) reported Deferred Federal Income Tax Expense (Benefit) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2021-03-01
- INOVIO PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2020 was $0.00.
- INOVIO PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2019 was -$263.00K.
- INOVIO PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2018 was $0.00.
- INOVIO PHARMACEUTICALS, INC. deferred federal income tax expense (benefit) for fiscal 2017 was $0.00.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2019-12-31 | -$263.00K 10-K · filed 2021-03-01 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-12 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-14 |
| 2015-12-31 | -$1.59M 10-K · filed 2018-03-14 |
| 2014-12-31 | $18.00K 10-K · filed 2017-03-15 |
| 2013-12-31 | $15.00K 10-K · filed 2016-03-14 |
| 2012-12-31 | $20.00K 10-K · filed 2015-03-16 |
| 2011-12-31 | $19.00K 10-K · filed 2014-03-17 |
| 2010-12-31 | $36.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |